Lipocine, Inc. (LPCN)
1.54
+0.01
(+0.65%)
USD |
NASDAQ |
Nov 06, 09:59
Lipocine Price to Book Value : 0.5833 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 0.5795 |
| November 04, 2026 | 0.5454 |
| November 03, 2026 | 0.553 |
| November 02, 2026 | 0.5492 |
| October 30, 2026 | 0.5454 |
| October 29, 2026 | 0.5757 |
| October 28, 2026 | 0.5719 |
| October 27, 2026 | 0.553 |
| October 26, 2026 | 0.5492 |
| October 23, 2026 | 0.5454 |
| October 22, 2026 | 0.553 |
| October 21, 2026 | 0.606 |
| October 20, 2026 | 0.6136 |
| October 19, 2026 | 0.5795 |
| October 16, 2026 | 0.5908 |
| October 15, 2026 | 0.6363 |
| October 14, 2026 | 0.6401 |
| October 13, 2026 | 0.6136 |
| October 12, 2026 | 0.6287 |
| October 09, 2026 | 0.6514 |
| October 08, 2026 | 0.731 |
| October 07, 2026 | 0.8332 |
| October 06, 2026 | 0.7954 |
| October 05, 2026 | 0.784 |
| October 02, 2026 | 0.7764 |
| Date | Value |
|---|---|
| October 01, 2026 | 0.784 |
| September 30, 2026 | 0.8332 |
| September 29, 2026 | 0.8181 |
| September 28, 2026 | 0.7916 |
| September 25, 2026 | 0.7954 |
| September 24, 2026 | 0.7916 |
| September 23, 2026 | 0.8029 |
| September 22, 2026 | 0.8181 |
| September 21, 2026 | 0.8484 |
| September 18, 2026 | 0.837 |
| September 17, 2026 | 0.8408 |
| September 16, 2026 | 0.8181 |
| September 15, 2026 | 0.8276 |
| September 14, 2026 | 0.8408 |
| September 11, 2026 | 0.8598 |
| September 10, 2026 | 0.8522 |
| September 09, 2026 | 0.8522 |
| September 08, 2026 | 0.8938 |
| September 04, 2026 | 0.9279 |
| September 03, 2026 | 0.9166 |
| September 02, 2026 | 0.8919 |
| September 01, 2026 | 0.8711 |
| August 31, 2026 | 0.8484 |
| August 28, 2026 | 0.8219 |
| August 27, 2026 | 0.8446 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 8.013 |
| ANI Pharmaceuticals, Inc. | 2.720 |
| Corcept Therapeutics, Inc. | 9.728 |
| Veru, Inc. | 1.244 |
| Eli Lilly & Co. | 32.04 |
Price to Book Value Related Metrics
| PS Ratio | 6.409 |
| PEG Ratio | -0.0068 |
| Price | 1.54 |
| Earnings Yield | -121.0% |
| Market Cap | 12.70M |
| PEGY Ratio | -0.0068 |